Best Folate Analog Metabolic Inhibitor for carcinoma, non-small-cell lung
3 Folate Analog Metabolic Inhibitor drugs indicated for carcinoma, non-small-cell lung, ranked by our independent rating. The current highest-rated is alimta. Compare them with all treatments for carcinoma, non-small-cell lung or the full Folate Analog Metabolic Inhibitor class. Not medical advice — always consult a professional.
Top folate analog metabolic inhibitor for carcinoma, non-small-cell lung: 1. Alimta · 2. Pemetrexed for Injection · 3. Pemfexy
| # | Drug | Rating | Type | Typical price | |
|---|---|---|---|---|---|
| 1 | Alimta | Not yet rated | Prescription | — | View → |
| 2 | Pemetrexed for Injection | Not yet rated | Prescription | — | View → |
| 3 | Pemfexy | Not yet rated | Prescription |
Full ranking · 3 drugs
alimta
PrescriptionFDA-sourced
Pemetrexed is a folate analog metabolic inhibitor.
folate analog metabolic inhibitorcarcinoma, non-small-cell lungneoplasms, mesothelial
Price varies
pemetrexed for injection
Frequently asked
- What is the best folate analog metabolic inhibitor for carcinoma, non-small-cell lung?
- By our independent rating, alimta currently ranks highest among Folate Analog Metabolic Inhibitor drugs used for carcinoma, non-small-cell lung. Ratings are based on FDA regulatory (recall-safety) data — always consult a professional.
- Which folate analog metabolic inhibitor drugs treat carcinoma, non-small-cell lung?
- pharmaranks lists 3 Folate Analog Metabolic Inhibitor products indicated for carcinoma, non-small-cell lung, per FDA drug-label data — each independently rated and ranked above.
- How are these ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.